Publication | Open Access
Poor Diagnostic Accuracy of Commercial Antibody-Based Assays for the Diagnosis of Acute Chikungunya Infection
60
Citations
11
References
2011
Year
Viral DiagnosticsImmunologyDiagnosisSample SensitivityDisease DetectionArbovirusCovid-19Commercial Antibody-based AssaysDiagnostic TestClinical EpidemiologySerologic TestingAcute DiagnosisInfection ControlEnzyme-linked Immunosorbent AssayPublic HealthDiagnostic VirologyVirologyAntibody ScreeningEpidemiologyAcute Chikungunya InfectionPoor Diagnostic AccuracyPathogenesisMedicine
A Sri Lankan fever cohort (n = 292 patients; 17.8% prevalence) was used to assess two standard diagnostic Chikungunya IgM tests. The immunochromatographic test (ICT) acute sample sensitivity (SN) was 1.9 to 3.9%, and specificity (SP) was 92.5 to 95.0%. The enzyme-linked immunosorbent assay (ELISA) gave an acute sample SN of 3.9% and an SP of 92.5% and a convalescent sample SN of 84% and an SP of 91%. These assays are not suitable for the acute diagnosis of Chikungunya virus infection.
| Year | Citations | |
|---|---|---|
Page 1
Page 1